Biotech company completes Shelton purchase
The company intends to move its operations to the new facility in a phased manner to minimize impact to ongoing projects, and expects to manufacture its drug candidates for human clinical trials at the new facility. The facility also includes a small office space, chemistry labs, biology labs and cl...
Mercura NYC • 1 day ago
No comments:
Post a Comment